| Target Price | $10.20 |
| Price | $1.52 |
| Potential |
571.05%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target BioAtla Inc 2027 .
The average BioAtla Inc target price is $10.20.
This is
571.05%
register free of charge
$10.50
590.79%
register free of charge
$10.10
564.47%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend BioAtla Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioAtla Inc stock has an average upside potential 2027 of
571.05%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -50.66 | -46.92 |
| 29.47% | 7.38% | |
| P/E | negative |
3 Analysts have issued a BioAtla Inc forecast for earnings per share. The average BioAtla Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JMP Securities |
Locked
➜
Locked
|
Locked | Aug 13 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Sep 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
JMP Securities:
Locked
➜
Locked
|
Aug 13 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 16 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


